No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample

Drug and Alcohol Dependence

Volumn 117, Issue 1, 2011, Pages 62-65

  Nikolov, Momchil A ^a,b   Beltcheva, Olga ^a   Galabova, Antoaneta ^b   Ljubenova, Anna ^c   Jankova, Elena ^c   Gergov, Galin ^b   Russev, Atanas A ^c   Lynskey, Michael T ^d   Nelson, Elliot C ^d   Nesheva, Eleonora ^b   Krasteva, Dorita ^b   Lazarov, Philip ^b   Mitev, Vanio I ^a   Kremensky, Ivo M ^e   Kaneva, Radka P ^a   Todorov, Alexandre A ^d  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Bulgarian Addictions Institute   (Bulgaria)

^c Initiative for Health Foundation   (Bulgaria)

^d WASHINGTON UNIVERSITY   (United States)

^e University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

Author keywords

118A>G; Association; Heroin dependence; OPRM1

Indexed keywords

ASPARAGINE; ASPARTIC ACID; DIAMORPHINE; MU OPIATE RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BULGARIA; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLYCOSYLATION; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADULT; ALLELES; ANALGESICS, OPIOID; BULGARIA; CASE-CONTROL STUDIES; EXONS; FEMALE; GENOTYPE; HEROIN DEPENDENCE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; RISK FACTORS; ROMANIA;

EID: 79959671535     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.12.026     Document Type: Article

References (31)

1. Arias A., Feinn R., Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend. 2006, 83:262-268.
2. Bart G., Kreek M.J., Ott J., LaForge K.S., Proudnikov D., Pollak L., Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005, 30:417-422.
3. Befort K., Filliol D., Decaillot F.M., Gaveriaux-Ruff C., Hoehe M.R., Kieffer B.L. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J. Biol. Chem. 2001, 276:3130-3137.
4. Beyer A., Koch T., Schroder H., Schulz S., Hollt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J. Neurochem. 2004, 89:553-560.
5. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9608-9613.
6. Crowley J.J., Oslin D.W., Patkar A.A., Gottheil E., DeMaria P.A., O'Brien C.P., Berrettini W.H., Grice D.E. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr. Genet. 2003, 13:169-173.
7. Deb I., Chakraborty J., Gangopadhyay P.K., Choudhury S.R., Das S. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J. Neurochem. 2010, 112:486-496.
8. Drakenberg K., Nikoshkov A., Horvath M.C., Fagergren P., Gharibyan A., Saarelainen K., Rahman S., Nylander I., Bakalkin G., Rajs J., Keller E., Hurd Y.L. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7883-7888.
9. Fillingim R.B., Kaplan L., Staud R., Ness T.J., Glover T.L., Campbell C.M., Mogil J.S., Wallace M.R. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J. Pain 2005, 6:159-167.
10. Franke P., Wang T., Nothen M.M., Knapp M., Neidt H., Albrecht S., Jahnes E., Propping P., Maier W. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am. J. Med. Genet. 2001, 105:114-119.
11. Gauderman, W.J., Morrison, J.M., 2006. Quanto 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. Available: http://hydra.usc.edu/gxe.
12. Glatt S.J., Bousman C., Wang R.S., Murthy K.K., Rana B.K., Lasky-Su J.A., Zhu S.C., Zhang R., Li J., Zhang B., Lyons M.J., Faraone S.V., Tsuang M.T. Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend. 2007, 90:159-165.
13. Gresham D., Morar B., Underhill P.A., Passarino G., Lin A.A., Wise C., Angelicheva D., Calafell F., Oefner P.J., Shen P., Tournev I., de Pablo R., Kucinskas V., Perez-Lezaun A., Marushiakova E., Popov V., Kalaydjieva L. Origins and divergence of the Roma (gypsies). Am. J. Hum. Genet. 2001, 69:1314-1331.
14. Hernandez-Avila C.A., Wand G., Luo X., Gelernter J., Kranzler H.R. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 118B:60-65.
15. Kapur S., Sharad S., Singh R.A., Gupta A.K. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. J. Integr. Neurosci. 2007, 6:511-522.
16. Kim S.G. Gender differences in the genetic risk for alcohol dependence - the results of a pharmacogenetic study in Korean alcoholics. Nihon Arukoru Yakubutsu Igakkai Zasshi 2009, 44:680-685.
17. Levran O., Londono D., O'Hara K., Nielsen D.A., Peles E., Rotrosen J., Casadonte P., Linzy S., Randesi M., Ott J., Adelson M., Kreek M.J. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav. 2008, 7:720-729.
18. Mague S.D., Isiegas C., Huang P., Liu-Chen L.Y., Lerman C., Blendy J.A. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10847-10852.
19. Oroszi G., Anton R.F., O'Malley S., Swift R., Pettinati H., Couper D., Yuan Q., Goldman D. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin. Exp. Res. 2009, 33:383-393.
20. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
21. Shabalina S.A., Zaykin D.V., Gris P., Ogurtsov A.Y., Gauthier J., Shibata K., Tchivileva I.E., Belfer I., Mishra B., Kiselycznyk C., Wallace M.R., Staud R., Spiridonov N.A., Max M.B., Goldman D., Fillingim R.B., Maixner W., Diatchenko L. Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum. Mol. Genet 2009, 18:1037-1051.
22. Shi J., Hui L., Xu Y., Wang F., Huang W., Hu G. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum. Mutat. 2002, 19:459-460.
23. Szeto C.Y., Tang N.L., Lee D.T., Stadlin A. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 2001, 12:1103-1106.
24. Tan E.C., Tan C.H., Karupathivan U., Yap E.P. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 2003, 14:569-572.
25. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002, 26:106-114.
26. Xu K., Lichtermann D., Lipsky R.H., Franke P., Liu X., Hu Y., Cao L., Schwab S.G., Wildenauer D.B., Bau C.H., Ferro E., Astor W., Finch T., Terry J., Taubman J., Maier W., Goldman D. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 2004, 61:597-606.
27. Yuferov V., Levran O., Proudnikov D., Nielsen D.A., Kreek M.J. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann. N. Y. Acad. Sci. 2010, 1187:184-207.
28. Zhang D., Shao C., Shao M., Yan P., Wang Y., Liu Y., Liu W., Lin T., Xie Y., Zhao Y., Lu D., Li Y., Jin L. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol. Psychiatry 2007, 61:1244-1251.
29. Zhang H., Luo X., Kranzler H.R., Lappalainen J., Yang B.Z., Krupitsky E., Zvartau E., Gelernter J. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum. Mol. Genet. 2006, 15:807-819.
30. Zhang L., Kendler K.S., Chen X. The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav. Brain Funct. 2006, 2:28.
31. Zhang Y., Wang D., Johnson A.D., Papp A.C., Sadee W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J. Biol. Chem. 2005, 280:32618-32624.